Position in VTRS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$37,102,063
+$6,307,342 QoQ
Shares Held
2,336,402
+2.5% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#58
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Swiss National Bank holds $505,151,346 across 28 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,121,700 | $139,643,196 | |
| 2 | ZTS |
Zoetis Inc.
|
1,186,032 | $85,228,259 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
111,255 | $60,281,296 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
268,900 | $45,320,406 | |
| 5 | VTRS |
Viatris Inc
This page
|
2,336,402 | $37,102,063 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,001,992 | $24,659,023 | |
| 7 | ALKS |
Alkermes plc.
|
316,900 | $16,605,560 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
130,654 | $14,494,754 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,102,063 | 2,336,402 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $30,794,721 | 2,279,402 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $28,620,084 | 2,298,802 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $22,530,439 | 2,275,802 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $20,332,734 | 2,276,902 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $29,322,232 | 3,366,502 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $41,976,444 | 3,371,602 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $41,016,992 | 3,532,902 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $37,377,227 | 3,516,202 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $42,896,861 | 3,592,702 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $40,623,351 | 3,751,002 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $38,027,081 | 3,856,702 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $43,130,585 | 4,321,702 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $46,298,193 | 4,812,702 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $54,852,001 | 4,928,302 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $44,762,589 | 5,253,825 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $54,846,309 | 5,238,425 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $56,991,888 | 5,238,225 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $62,189,630 | 4,596,425 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $64,740,883 | 4,777,925 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $71,784,743 | 5,023,425 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $70,660,609 | 5,058,025 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $91,635,320 | 4,889,825 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||